Even though AS patients had a higher prevalence of Alzheimer's disease compared to the general population, among the patients with AS, those treated with TNF inhibitors had lower rates of Alzheimer's disease [60]. The gene discussed is TNF; the disease is early-onset autosomal dominant Alzheimer disease.